Argonaute-2

Product Inquiry

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
NitisinoneSC-0735; SYN-118; NTBCApprovedSwedish Orphan Biovitrum AgOrfadin, NityrUnited StatesTyrosinemiasSwedish Orphan Biovitrum Ag2002-01-18Alkaptonuria; Blindness; Tyrosinemias; Albinism
Details
  • Product Inquiry
  • Marketed Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland